Skip to main content
main-content

Zeitschrift

Journal of Cancer Research and Clinical Oncology

Journal of Cancer Research and Clinical Oncology 10/2004

Ausgabe 10/2004

Inhaltsverzeichnis ( 8 Artikel )

01.10.2004 | Original Paper | Ausgabe 10/2004

A phase II trial of FUdR in patients with advanced pancreatic cancer

Bach Ardalan, Mayra Lima

01.10.2004 | Original Paper | Ausgabe 10/2004

Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells

Ryuji Yasumatsu, Torahiko Nakashima, Muneyuki Masuda, Aya Ito, Yuichiro Kuratomi, Takashi Nakagawa, Shizuo Komune

01.10.2004 | Original Paper | Ausgabe 10/2004

Methylenetetrahydrofolate reductase C677T polymorphism and predisposition towards esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population

Jianhui Zhang, Rainer B. Zotz, Yan Li, Rui Wang, Sybille Kiel, Wolfgang A. Schulz, Denggui Wen, Zhifeng Chen, Liwei Zhang, Shijie Wang, Helmut E. Gabbert, Mario Sarbia

01.10.2004 | Original Paper | Ausgabe 10/2004

Quality of adjuvant CMF chemotherapy for node-positive primary breast cancer: a population-based study

Michael Schaapveld, Elisabeth G. E. de Vries, Winette T. A. van der Graaf, Renée Otter, Pax H. B. Willemse

01.10.2004 | Original Paper | Ausgabe 10/2004

Potent antitumoral efficacy of a novel replicative adenovirus CNHK300 targeting telomerase-positive cancer cells

C.-Q. Su, J. Sham, H.-B. Xue, X.-H. Wang, D. Chua, Z.-F. Cui, L.-H. Peng, L.-F. Li, L.-H. Jiang, M.-C. Wu, Q.-J. Qian

01.10.2004 | Original Paper | Ausgabe 10/2004

Gefitinib (‘IRESSA’, ZD1839) inhibits EGF-induced invasion in prostate cancer cells by suppressing PI3 K/AKT activation

Lorella Bonaccorsi, Sara Marchiani, Monica Muratori, Gianni Forti, Elisabetta Baldi

01.10.2004 | Original Paper | Ausgabe 10/2004

Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins

Jie-Feng Cui, Yin-Kun Liu, Bo-Shen Pan, Hai-Yan Song, Yu Zhang, Rui-Xia Sun, Jie Chen, Ju-Tao Feng, Zhao-You Tang, Yan-Ling Yu, Hua-Li Shen, Peng-Yuan Yang

01.10.2004 | Rapid Communication | Ausgabe 10/2004

Tumour lysis syndrome in multiple myeloma after bortezomib (VELCADE) administration

Evangelos Terpos, Marianna Politou, Amin Rahemtulla

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise